色素沉淀疾病治疗市场 - 按治疗类型、疾病类型 - 全球预测 2024 - 2032

Pigmentation Disorder Treatment Market - By Treatment Type, Type of Disorder - Global Forecast 2024 - 2032

出版日期: 2024年03月15日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于全球人口对色素沉着疾病及其对皮肤健康影响的认识不断提高，色素沉着疾病治疗市场规模在 2024 年至 2032 年间可能会实现 5.8% 的复合年增长率。随着人们越来越注重自己的外表并寻求解决皮肤问题，对先进色素沉着治疗的需求不断增加。此外，皮肤病学研究和医疗技术的进步促进了创新治疗方案的发展。

随着寿命的延长和暴露于紫外线辐射等环境因素的影响，黄褐斑、色素沉着过度和白斑症等色素沉着疾病的盛行率进一步增加。根据全球白斑症基金会的数据，白斑影响全世界 7,000 万人，不存在种族、民族或性别的障碍。大约20-35%的白斑症患者是儿童。因此，对安全、有效和微创治疗方案来管理这些疾病的需求不断增长。社群媒体和美容标准的影响力日益增强，激发了人们对完美肌肤的渴望，进一步推动了对色素沉着疗程的需求

整个产业分为治疗类型、疾病类型和地区。

根据治疗类型，预计到 2032 年，手术领域的色素沉着障碍治疗市场价值复合年增长率将达到 5.5%。这是由于对旨在有效解决色素沉着障碍的先进皮肤科手术的需求不断增加。雷射治疗、化学换肤、微晶磨皮和强烈脉衝光 (IPL) 治疗等手术可为各种色素沉着问题提供有针对性的精确解决方案。此外，程序技术的进步正在改善治疗结果，同时最大限度地减少停机时间和副作用，从而提高患者满意度。

就疾病类型而言，由于色素沉着过度的广泛流行和消费者意识的提高，预计从 2024 年到 2032 年，色素沉着过度治疗市场的复合年增长率将达到 5.7%。由于阳光照射、荷尔蒙波动和老化等因素会导致色素沉着过度，因此对有效治疗方案来解决这一常见皮肤问题的需求不断增长。专门针对色素沉着过度客製化的治疗方式的进步，以及专业护肤服务的不断增加，也有利于该细分市场的成长。

由于人口多样化和气候条件变化，2024年至2032年间，亚太地区色素沉着障碍治疗产业规模将以复合年增长率6.4%的速度快速扩张。发病率的增加，加上可支配收入的增加和人们对皮肤护理意识的不断增强，正在推动对有效治疗方案的需求。先进皮肤科手术和护肤技术的不断普及以及药妆品的日益普及将进一步推动亚太地区的市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 越来越多地采用先进的皮肤护理程序
  - 色素沉淀疾病的盛行率不断增加
  - 皮肤科治疗支出不断增加
  - 年轻人对皮肤健康的认识不断提高
- 产业陷阱与挑战
  - 整容手术费用高
  - 缺乏报销政策
成长潜力分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪錶板

第 5 章：市场估计与预测：按治疗类型，2018 - 2032 年

主要趋势
药品
- 按类型
  - 皮质类固醇
  - 黑色素细胞刺激激素
  - 其他药品
- 依给药途径
  - 口服
  - 专题
  - 其他给药途径
- 按配销通路
  - 医院药房
  - 零售药局
  - 网路药局
程式
- 按类型
  - 雷射治疗
  - 光疗
  - 磨皮术
  - 其他手续
- 按最终用户
  - 医院
  - 皮肤科诊所
  - 美容中心
  - 其他最终用户

第 6 章：市场估计与预测：按疾病类型，2018 年 - 2032 年

主要趋势
色素沉淀不足
- 白斑
- 白化病
- 其他色素沉着不足
色素沉着过度
- 黄褐斑
- 雀斑痣
- 发炎后色素沉着（PIH）
- 其他色素沉着过度

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 8 章：公司简介

AbbVie Inc.
Candela Corporation
Cipher Pharmaceuticals Inc.
Galderma
GSK plc
Incyte
L'Oréal Paris
Novartis AG
Pfizer Inc.
Pierre Fabre group
Shiseido Company Limited

简介目录

Product Code: 8528

Pigmentation disorder treatment market size is likely to register 5.8% CAGR between 2024 to 2032, driven by the increasing awareness among the global population about pigmentation disorders and their impact on skin health. As individuals are becoming more conscious about their appearance and seeking to address skin concerns, the demand for advanced pigmentation treatments is on the rise. Additionally, advancements in dermatological research and medical technology have led to the development of innovative treatment options.

With increasing longevity and exposure to environmental factors like UV radiation, the prevalence of pigmentation disorders, such as melasma, hyperpigmentation, and vitiligo is further growing. As per Global Vitiligo Foundation, vitiligo affects 70 million people worldwide, with no barriers based on race, ethnicity, or gender. Around 20-35% of vitiligo patients are children. As a result, there is a growing demand for safe, effective, and minimally invasive treatment options to manage these conditions. The growing influence of social media and beauty standards has fueled the desire for flawless skin, further driving the demand for pigmentation treatments

The overall industry is segmented the into treatment type, type of disorder, and region.

Based on treatment type, the pigmentation disorder treatment market value from the procedures segment is anticipated to witness 5.5% CAGR through 2032. This is due to the increasing demand for advanced dermatological procedures aimed at addressing pigmentation disorders effectively. Procedures, such as laser therapy, chemical peels, microdermabrasion, and intense pulsed light (IPL) treatments offer targeted and precise solutions for various pigmentation concerns. Moreover, advancements in procedural techniques and technologies are improving treatment outcomes while minimizing downtime and side effects for enhancing patient satisfaction.

In terms of type of disorder, the hyperpigmentation segment in the pigmentation disorder treatment market is estimated to record 5.7% CAGR from 2024 to 2032, due to its widespread prevalence and increasing awareness among consumers. With factors, such as sun exposure, hormonal fluctuations, and aging contributing to the development of hyperpigmentation, there is a growing demand for effective treatment options to address this common skin concern. Advancements in treatment modalities tailored specifically for hyperpigmentation, along with the growing availability of professional skincare services are also favoring the segment growth.

Asia Pacific pigmentation disorder treatment industry size will witness rapid expansion at 6.4% CAGR between 2024-2032, attributed to the diverse population and varying climate conditions. This increased incidence, coupled with rising disposable incomes and growing awareness about skincare is fueling the demand for effective treatment options. The expanding availability of advanced dermatological procedures and skincare technologies along with the rising adoption of cosmeceuticals will further propel the market growth in the Asia Pacific.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing adoption of advanced skin care procedures
  - 3.2.1.2 Increasing prevalence of pigmentation disorders
  - 3.2.1.3 Growing expenditure on dermatological treatments
  - 3.2.1.4 Rising awareness regarding skin health among younger population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of cosmetic procedures
  - 3.2.2.2 Lack of reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Drugs
- 5.2.1 By type
  - 5.2.1.1 Corticosteroids
  - 5.2.1.2 Melanocyte-stimulating hormone
  - 5.2.1.3 Other drugs
- 5.2.2 By route of administration
  - 5.2.2.1 Oral
  - 5.2.2.2 Topical
  - 5.2.2.3 Other routes of administrations
- 5.2.3 By distribution channel
  - 5.2.3.1 Hospital pharmacies
  - 5.2.3.2 Retail pharmacies
  - 5.2.3.3 Online pharmacies
5.3 Procedures
- 5.3.1 By type
  - 5.3.1.1 Laser treatment
  - 5.3.1.2 Phototherapy
  - 5.3.1.3 Dermabrasion
  - 5.3.1.4 Other procedures
- 5.3.2 By end-user
  - 5.3.2.1 Hospitals
  - 5.3.2.2 Dermatology clinics
  - 5.3.2.3 Aesthetic centers
  - 5.3.2.4 Other end-users

Chapter 6 Market Estimates and Forecast, By Type of Disorder, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hypopigmentation
- 6.2.1 Vitiligo
- 6.2.2 Albinism
- 6.2.3 Other hypopigmentations
6.3 Hyperpigmentation
- 6.3.1 Melasma
- 6.3.2 Lentigines
- 6.3.3 Post-inflammatory hyperpigmentation (PIH)
- 6.3.4 Other hyperpigmentations

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East and Africa